XML 45 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-based Compensation - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Feb. 27, 2020
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Weighted average exercise price, issued   $ 2.98    
Number of shares, vested   99,260    
Stock-based compensation expense recognized   $ 3,750 $ 3,792  
Accrued expenses   6,687   $ 5,877
Unrecognized stock-based compensation expense related to unvested options granted   $ 14,300    
CAD        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Weighted average period for recognition of unvested options granted   2 years 4 months 24 days    
USD        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Number of shares, granted   63,600    
Weighted average period for recognition of unvested options granted   3 years 9 months 18 days    
General and Administrative        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Stock-based compensation expense recognized   $ 1,941 $ 1,787  
Restricted Share Units        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Number of shares, granted   1,048,930    
Stock-based compensation expense recognized   $ 2,000    
Unrecognized stock-based compensation expense related to unvested options granted   $ 20,000    
Restricted Share Units | CAD        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Weighted average period for recognition of unvested options granted   2 years 6 months    
Restricted Share Units | USD        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Number of shares, granted   1,048,930    
Weighted average period for recognition of unvested options granted   4 years    
Directors' Deferred Share Unit Plan | General and Administrative        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Accrued expenses   $ 200    
Stock Option        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Stock-based compensation expense recognized   $ 1,700    
MindMed Stock Option Plan        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Vesting percentage 15.00%      
Vesting rights, description     The Plan was approved by the shareholders as part of the terms of an arrangement agreement (the “Arrangement”) entered into by the Company on October 15, 2019 in connection with the completion of its reverse acquisition, which completed on February 27, 2020 (the “Transaction”) and is authorized to issue 15% of the Company’s outstanding Common Shares under the terms of the Plan.